GIOSTAR Co-Founder Discusses Stem Cells with Healthcare Weekly

Dr. Anand Srivastava | Chairman | GIOSTAR

Dr. Anand Srivastava, Chairman and Co-Founder of GIOSTAR, recently spoke with Healthcare Weekly about stem cell science, and its potential role in combating COVID-19. The discussion was facilitated by Healthcare Weekly CEO Codrin Arsene, and touched on numerous topics including:

  • The modern approach to stem cell therapy: regenerative medicine
  • How the coronavirus could impact perceptions of stem cell research
  • Why we need a multiple approach strategy to tackle COVID-19

Click here to listen to the podcast.

About Healthcare Weekly

Healthcare Weekly is a prominent Chicago-based portal that provides leaders in healthcare a forum for exchanging ideas and keeping abreast of industry trends (i.e., artificial intelligence, augmented / virtual reality, and mobility technologies).

For more information, please visit

Interested in Hearing More?

Please complete this brief form to learn more about Dr. Srivastava’s pioneering research on stem cells, and how GIOSTAR may be able to help you. You can also reach out to us via phone ((844) 446 7827) or email ( We look forward to being a part of your healing journey!

Written by GIOSTAR Chicago

GIOSTAR Chicago offers cutting-edge regenerative medicine techniques and protocols that have been extensively researched and developed by our leading scientists. Our team consists of world-renowned authorities in stem cell biology, protein biochemistry, molecular biology, immunology, in utero transplantation of stem cell, tissue targeting, gene therapy and clinical research. GIOSTAR Chicago physicians are highly-credential health care professionals, offering personalized patient care to patients suffering from a broad range of degenerative diseases.